In silico Platform for designing genome-based
Personalized immunotherapy or Vaccine against Cancer

Predicted Immune Epitope Results

The result page of search shows exclusive peptide/epitopes generated due to mutation [Neoepitope], the tissue of origin [Tissue], position of peptide in protein [Position], number of mismatches counted by aligning mutated and normal protein sequence [Num Mismatch, percentage of cell lines with this peptide over total number of cell lines [Promiscuity %]. The immune information include CTL epitopes (Yes/No), MHC I binders, MHC II binders (both given as number of alleles) and B cell epitopes (Yes/No). For more information, please click HERE

NeoepitopesWCPMSRLRL        Click here to BLAST against human proteome
CTL Epitope
HLA I Alleles
(ProPred I)
HLA-B14, HLA-B*3902, HLA-B*51, HLA-B*5301, HLA-B*5401, HLA-B60, HLA-B7, HLA-B8, MHC-Dd9
HLA I Alleles
HLA II Alleles
DRB1_0701, DRB1_0703, DRB1_0801, DRB1_0802, DRB1_0813, DRB1_0817, DRB1_1101, DRB1_1114, DRB1_1120, DRB1_1128, DRB1_1302, DRB1_1305, DRB1_1307, DRB1_1321, DRB1_1323, DRB1_1501, DRB1_1502, DRB1_1506, DRB5_0101, DRB5_010520

CANCERTOPE    |     Raghava's Group    |     IMTECH    |     CSIR    |     CRDD    |     GPSR Package